The Cigna Group
CI
$329.44
$0.810.25%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 28.62% | 30.54% | 24.62% | 23.19% | 11.60% |
| Total Other Revenue | -4.48% | -73.52% | 15.47% | 4.69% | 36.79% |
| Total Revenue | 28.44% | 29.86% | 24.57% | 23.08% | 11.72% |
| Cost of Revenue | 32.88% | 34.13% | 27.15% | 25.59% | 11.18% |
| Gross Profit | -1.69% | 1.85% | 6.64% | 6.19% | 15.52% |
| SG&A Expenses | -0.19% | -1.76% | 5.50% | 3.55% | 7.88% |
| Depreciation & Amortization | -5.99% | -3.96% | -7.69% | -7.84% | -1.31% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.98% | 30.99% | 25.20% | 23.49% | 10.79% |
| Operating Income | -3.25% | 8.23% | 11.37% | 14.08% | 35.00% |
| Income Before Tax | 968.62% | -35.22% | 5.57% | -95.07% | -86.16% |
| Income Tax Expenses | 151.47% | -6.14% | -3.74% | -1.36% | -775.74% |
| Earnings from Continuing Operations | 38.75% | -43.06% | 7.88% | -116.23% | -9.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -43.59% | -109.76% | -62.00% | -66.67% | -168.97% |
| Net Income | 38.39% | -47.51% | 6.03% | -121.86% | -13.75% |
| EBIT | -3.25% | 8.23% | 11.37% | 14.08% | 35.00% |
| EBITDA | -6.25% | 2.65% | 7.91% | 9.96% | 25.88% |
| EPS Basic | 46.75% | -44.57% | 11.07% | -122.57% | -10.57% |
| Normalized Basic EPS | -0.96% | 11.66% | 15.71% | 20.79% | 37.02% |
| EPS Diluted | 46.76% | -44.51% | 10.77% | -122.88% | -10.53% |
| Normalized Diluted EPS | -0.96% | 11.65% | 15.44% | 22.13% | 37.02% |
| Average Basic Shares Outstanding | -5.70% | -5.31% | -4.54% | -3.13% | -3.55% |
| Average Diluted Shares Outstanding | -5.70% | -5.30% | -4.32% | -4.19% | -3.55% |
| Dividend Per Share | 13.82% | 13.82% | 13.82% | 13.82% | 9.82% |
| Payout Ratio | -0.22% | 1.05% | 0.02% | -5.98% | 0.24% |